Ocular Therapeutix, Inc. - Common Stock (OCUL)
7.1950
+0.6950 (10.69%)
Ocular Therapeutics is a biotechnology company focused on developing innovative therapies for eye diseases and conditions
The company is primarily engaged in the research and development of unique drug delivery solutions that aim to improve the effectiveness and safety of treatments for various ocular diseases. Ocular Therapeutics leverages advanced technology platforms to create products that can provide sustained release of medication, enhancing patient compliance and outcomes. Their pipeline includes therapies targeting conditions such as retinal diseases and dry eye, positioning the company at the forefront of addressing significant unmet needs in the field of ophthalmology.
| Previous Close | 6.500 |
|---|---|
| Open | 6.530 |
| Bid | 7.190 |
| Ask | 7.200 |
| Day's Range | 6.510 - 7.210 |
| 52 Week Range | 4.060 - 11.78 |
| Volume | 1,253,330 |
| Market Cap | 1.13B |
| PE Ratio (TTM) | -5.756 |
| EPS (TTM) | -1.3 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 1,153,370 |
